NewsBenzingaTonix Pharma presenta i dati dell’analisi degli studi di fase 3 RELIEF e RESILIENT su TONMYA per il trattamento della fibromialgia negli adulti, all’IASP 2026 World Congress Tonix Pharma presenta i dati dell’analisi degli studi di fase 3 RELIEF e RESILIENT su TONMYA per il trattamento della fibromialgia negli adulti, all’IASP 2026 World Congress Benzinga 2026.10.27 11:05 (GMT+0) Open on Benzinga Other news Why Microsoft Thinks Smaller, Cheaper AI Can Beat Claude and GPT Here’s How Much You Would Have Made Owning Royal Caribbean Group Stock In The Last 15 Years Nvidia says its open-source AI strategy remains intact after Jensen Huang’s exit $1000 Invested In Teck Resources 5 Years Ago Would Be Worth This Much Today 'Microsoft Executive Says Nvidia Drama Could Boost Rival Chips'- Bloomberg Nvidia says it doesn’t plan to reappoint Jensen Huang as CEO